Systematic review: the efficacy of intermittent and on‐demand therapy with histamine H2‐receptor antagonists or proton pump inhibitors for gastro‐oesophageal reflux disease patients
Open accessThe DOI matches its Crossref record.
Abstract
Summary: Aim : To perform a systematic review on the efficacy of intermittent and on‐demand therapy with either histamine H 2‐receptor antagonists or proton pump inhibitors for patients with erosive oesophagitis or symptomatic heartburn. Method : We conducted randomized‐controlled trials of non‐continuous therapy in gastro‐oesophageal reflux disease patients. Results : Fourteen studies met inclusion criteria. Because of variation in outcome measures statistical pooling of results was not possible. Results were analysed qualitatively. Four studies evaluated intermittent therapy of treatment 3 days a week with omeprazole 20 mg or daily with ranitidine which were not efficacious compared to a daily proton pump inhibitor. Famotidine 10 and 20 mg, ranitidine 75 mg and cimetidine 200 mg were efficacious in five on‐demand studies for relief of symptomatic heartburn episodes. In three of four studies, evaluating only non‐erosive (endoscopy‐negative) gastro‐oesophageal reflux disease patients, esomeprazole 20 and 40 mg and omeprazole 10 and 20 mg a day were efficacious using willingness to continue as an endpoint. Lansoprazole 30 mg and omeprazole 20 mg maintained symptom control in 60–70% of healed oesophagitis patients. Conclusions : Intermittent proton pump inhibitor or H 2‐receptor antagonist therapy is not effective in maintaining control in oesophagitis patients. H 2‐receptor antagonists are effective for relief of heartburn episodes. On‐demand proton pump inhibitor therapy may work in a proportion of non‐erosive gastro‐oesophageal reflux disease patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Gastro-oesophageal reflux disease
Moayyedi, P., & Talley, N. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68932-0 · Cited by 426
Acid Suppression Therapy: Where Do We Go from Here?
Scarpignato, C., Pelosini, I., & Di Mario, F. (2006) · Digestive Diseases · doi:10.1159/000091298 · Cited by 119
Effect of proton-pump inhibitor therapy on serum chromogranin A level.
Pregun, I., Herszényi, L., Juhász, M., Miheller, P., Hritz, I., Patócs, A., Rácz, K., & Tulassay, Z. (2011) · Digestion · doi:10.1159/000321535 · Cited by 89
Metadata
- Authors
- Zacny, J., Zamakhshary, M., Sketris, I., & Veldhuyzen van Zanten, S.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 21
- Issue
- 11
- Pages
- 1299-1312
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W1964829068
- Cited by
- 61
- References
- 0
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic review: the efficacy of intermittent and on‐demand therapy with histamine H2‐receptor antagonists or proton pump inhibitors for gastro‐oesophageal reflux disease patients. https://app.cochat.ai/papers/10.1111/j.1365-2036.2005.02490.x
- The paper
- Zacny, J., Zamakhshary, M., Sketris, I., & Veldhuyzen van Zanten, S. (2005). Systematic review: the efficacy of intermittent and on‐demand therapy with histamine H2‐receptor antagonists or proton pump inhibitors for gastro‐oesophageal reflux disease patients. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2005.02490.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.